Revolution Medicines Inc RVMD

NAS: RVMD | ISIN: US76155X1000 30/04/2025

40,38 USD (-0,71%)

(-0,71%) 30/04/2025

Grafiek Revolution Medicines Inc

Grafiek Revolution Medicines Inc

1 dag1d -0,71%
1 week1w 4,67%
1 maand1m 20,11%
3 maanden3m -4,18%
6 maanden6m -26,70%
1 jaar1j 4,02%
5 jaar5j 36,93%

Revolution Medicines Inc in het nieuws

Toon enkel gratis nieuws

11 maart 2021 · Revolution Medicines Announces Six Presentations at the American Association for Cancer Research Annual Meeting 2021 · Persbericht

9 maart 2021 · Revolution Medicines to Participate in Upcoming Investor Conferences · Persbericht

2 maart 2021 · Revolution Medicines Reports Fourth Quarter and Year-End 2020 Financial Results and Update on Corporate Progress · Persbericht

8 februari 2021 · Revolution Medicines Announces Closing of Upsized Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares · Persbericht

4 februari 2021 · Revolution Medicines Announces Pricing of Upsized $260.9 Million Public Offering of Common Stock · Persbericht

1 februari 2021 · Revolution Medicines Announces Proposed Public Offering of Common Stock · Persbericht

5 januari 2021 · Revolution Medicines to Provide R&D Pipeline Update, Including Progress of RAS(ON) Inhibitor Programs, During Presentation at 39th Annual J.P. Morgan Healthcare Conference · Persbericht

Profiel Revolution Medicines Inc

Farmaceutische producten: Andere

Gezondheidstechnologie

Productie van biologische producten

Website: revolutionmedicines.com

Hoofdzetel: Redwood City, California Verenigde Staten

CEO: Mark Goldsmith

Werknemers: 247

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe